Education
About Us
Working with TipRanks
Follow Us
Kontafarma China Holdings Ltd (HK:1312)
:1312
1312 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.02 - HK$0.05
Previous CloseN/A
Volume162.00K
Average Volume (3M)884.40K
Market Cap
HK$150.63M
Enterprise ValueHK$392.31M
Total Cash (Recent Filing)HK$77.66M
Total Debt (Recent Filing)HK$333.82M
Price to Earnings (P/E)―
Beta0.05
Next Earnings
Sep 01, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 27, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding5,588,572,000
10 Day Avg. Volume951,000
30 Day Avg. Volume884,400
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Kontafarma China Holdings Ltd News
PremiumCompany Announcements
Kontafarma China Holdings Reports Increased Revenue but Higher Losses in 2024
PremiumCompany Announcements
Kontafarma China Holdings to Review Annual Results and Dividend
PremiumCompany Announcements
Kontafarma China Announces Increased Losses Despite Revenue Growth
PremiumCompany Announcements
Kontafarma China Holdings Updates on 2024 Master Tenancy Agreement
PremiumCompany Announcements
Kontafarma Extends Tenancy Agreement with Key Subsidiary
PremiumCompany Announcements
Kontafarma China Announces Change in Share RegistrarPremiumCompany Announcements
Kontafarma China Moves Business Hub in Hong Kong
PremiumCompany Announcements
Kontafarma Announces Subsidiary Legal Update---
1312 FAQ
What was Kontafarma China Holdings Ltd’s price range in the past 12 months?
Kontafarma China Holdings Ltd lowest stock price was HK$0.02 and its highest was HK$0.05 in the past 12 months.
What is Kontafarma China Holdings Ltd’s market cap?
Kontafarma China Holdings Ltd’s market cap is HK$150.63M.
When is Kontafarma China Holdings Ltd’s upcoming earnings report date?
Kontafarma China Holdings Ltd’s upcoming earnings report date is Sep 01, 2025 which is in 148 days.
How were Kontafarma China Holdings Ltd’s earnings last quarter?
Kontafarma China Holdings Ltd released its earnings results on Mar 28, 2025. The company reported -HK$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.014.
Is Kontafarma China Holdings Ltd overvalued?
According to Wall Street analysts Kontafarma China Holdings Ltd’s price is currently Overvalued.
Does Kontafarma China Holdings Ltd pay dividends?
Kontafarma China Holdings Ltd pays a Notavailable dividend of HK$0.003 which represents an annual dividend yield of N/A. See more information on Kontafarma China Holdings Ltd dividends here
What is Kontafarma China Holdings Ltd’s EPS estimate?
Kontafarma China Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kontafarma China Holdings Ltd have?
Kontafarma China Holdings Ltd has 5,588,572,000 shares outstanding.
What happened to Kontafarma China Holdings Ltd’s price movement after its last earnings report?
Kontafarma China Holdings Ltd reported an EPS of -HK$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Kontafarma China Holdings Ltd?
Currently, no hedge funds are holding shares in HK:1312
---
Kontafarma China Holdings Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-20.58%
12-Months-Change
Fundamentals
Return on Equity
-7.42%
Trailing 12-Months
Asset Growth
-8.10%
Trailing 12-Months
Company Description
Kontafarma China Holdings Ltd
Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides consultation services for fitness and health activities. The company trades in laboratory related products; researches and develops medical products; and offers corporate advisory services. As of December 31, 2021, it operated 12 fitness centers and 2 yoga center in Taiwan; and 10 fitness centers in Singapore. The company was formerly known as Allied Cement Holdings Limited and changed its name to Tongfang Kontafarma Holdings Limited in August 2016. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Tongfang Kontafarma Holdings Limited is a subsidiary of China Health Management Investment Limited.
---
Technical Analysis
China Energy Engineering Corp. Ltd. Class H
―
Good Fellow Healthcare Holdings Limited
―
Kingworld Medicines Group Ltd.
―
Link-Asia International Medtech Group Ltd.
―
Tang Palace (China) Holdings Limited
―
---